Search Results - "Mileshkin, L. R."

Indianapolis Consensus Recommendations for Promoting Diversity and Equity in Cancer Clinical Trials: "The Indianapolis Black Paper".

Authors: Birhiray, Maya N. Hantel, Andrew Mikhael, Joseph R. et al.

Source: Diversity & Inclusion Research. Jul2026, Vol. 3 Issue 3, p1-11. 11p.

Author Index.

Source: Asia Pacific Journal of Clinical Oncology. Aug2019 Supplement S5, Vol. 15, p101-104. 4p.

Triple M Syndrome Associated With Concurrent Durvalumab and Olaparib Therapy in Metastatic Cholangiocarcinoma: A Case Report.

Authors: Nilsen, Oliver Senko, Clare Collins, Allison et al.

Source: Case Reports in Oncological Medicine. 6/22/2026, Vol. 2026, p1-6. 6p.

Author Index.

Source: Asia Pacific Journal of Clinical Oncology. Aug2018 Supplement S3, Vol. 14, p76-78. 3p.

The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer.

Authors: Zhang H Luo X Jiang J et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Mar 03; Vol. 10 (1). Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Impact of the revised FIGO 2018 staging system on survival outcomes with respect to prognostic factors in cervical cancer patients treated in a tertiary care cancer center in South Karnataka.

Authors: Sindhu, K R Pranitha, S L Arpitha, S et al.

Source: Journal of Cancer Research & Therapeutics. Jan-Mar2026, Vol. 22 Issue 1, p27-35. 9p.

Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older.

Authors: Mileshkin, L. R. Seymour, J. F. Wolf, M. M. et al.

Source: Leukemia & Lymphoma. Nov2005, Vol. 46 Issue 11, p1575-1579. 5p. 4 Charts, 2 Graphs.

Clinical benefit of hormonal therapy in advanced ovarian cancer.

Authors: Bei, L. Silva, A. V. Petiz, A. et al.

Source: European Journal of Gynaecological Oncology. 2020, Vol. 41 Issue 1, p98-101. 4p.

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment Changes.

Authors: Anca-Stanciu, Maria-Bianca Manu, Andrei Olinca, Maria Victoria et al.

Source: Journal of Clinical Medicine. Feb2025, Vol. 14 Issue 4, p1385. 22p.

Soft multiclass feature augmented deep learning to predict tumor origins using cytology or histology whole slide images.

Authors: Wang CW Lai PJ Chu TC et al.

Source: NPJ digital medicine [NPJ Digit Med] 2026 Apr 13; Vol. 9 (1). Date of Electronic Publication: 2026 Apr 13.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101731738 Publication Model: Electronic Cited Medium: Internet ISSN: 2398-6352 (Electronic) Linking ISSN: 23986352 NLM ISO Abbreviation: NPJ Digit Med Subsets: PubMed not MEDLINE

宫颈癌诊治热点与进展.

Alternate Title: Hotspots and advances on diagnosis and treatment for cervical cancer.

Authors: 张清伟 尹如铁

Source: Journal of Practical Medicine / Shiyong Yixue Zazhi. 9/10/2024, Vol. 40 Issue 17, p2357-2362. 6p.

Systematic in silico analysis suggests a protective role for progesterone receptor in pancreatic adenocarcinoma.

Authors: Ozcan, Gulbahar Boyuk Sut, Burcu Biterge

Source: Cuestiones de Fisioterapia. 2024, Vol. 53 Issue 3, p5220-5236. 17p.

The Leaf Extract of Mitrephora chulabhorniana Suppresses Migration and Invasion and Induces Human Cervical Cancer Cell Apoptosis through Caspase-Dependent Pathway.

Authors: Nimlamool, Wutigri Chansakaow, Sunee Potikanond, Saranyapin et al.

Source: BioMed Research International. 5/24/2022, p1-13. 13p.

Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications.

Authors: Kuhn, Elisabetta Gambini, Donatella Runza, Letterio et al.

Source: Cancers. Jul2024, Vol. 16 Issue 13, p2458. 26p.

Pyrazinamide Analogs Designed for Rational Drug Designing Strategies Against Resistant Tuberculosis (A Review).

Authors: Wang, Xinyu Hu, Hongshang Zhou, Wenhao et al.

Source: Russian Journal of Bioorganic Chemistry. Feb2024, Vol. 50 Issue 1, p8-27. 20p.

LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI.

Authors: Tian, Ping Feng, Yuanyuan Tao, Ling

Source: Chemical Biology & Drug Design. Jan2024, Vol. 103 Issue 1, p1-12. 12p.

The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.

Authors: Ding, Hao Xiong, Xiao-Xing Fan, Guan-Lan et al.

Source: BioMed Research International. 4/13/2020, p1-9. 9p.

Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.

Authors: Dust, Kerry Carpenter, Michael Chen, Julie Chih-yu et al.

Source: Viruses (1999-4915). Aug2022, Vol. 14 Issue 8, p1764-1764. 24p.

Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.

Authors: Jiang, Yu Song, Baozhi Chen, Zhiqin

Source: Computational & Mathematical Methods in Medicine. 6/1/2022, p1-8. 8p.

Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.

Authors: Reza, Md. Selim Harun-Or-Roshid, Md. Islam, Md. Ariful et al.

Source: International Journal of Molecular Sciences. Apr2022, Vol. 23 Issue 7, p3968-N.PAG. 21p.